A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Clinical trial NCT07645924 · RECRUITING
Trial details
- NCT number
- NCT07645924
- Sponsor
- Kallyope Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-02-01
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.